Home › Funds › PNC Financial Services › LCTX
PNC Financial Services position in LCTX
LINEAGE CELL THERAPEUTICS IN · Health Care
Latest position (Q4 2025)252 sh
Reported value held$421
Portfolio Weight0.00%
First reportedQ4 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 180 | $196 | New |
| Q4 2024 | 8 | $4 | New |
| Q1 2025 | 46 | $21 | Add |
| Q2 2025 | 401 | $364 | Add |
| Q3 2025 | 397 | $671 | Reduce |
| Q4 2025 | 252 | $421 | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LCTX
- BlackRock Inc 13.19M sh · $17.27M · Q2 2026
- Vanguard Group 9.64M sh · $16.11M · Q4 2025
- Geode Capital Management 5.30M sh · $6.94M · Q2 2026
- Millennium Management 3.02M sh · $3.95M · Q2 2026
- Northern Trust Corp 1.66M sh · $2.17M · Q2 2026
- Morgan Stanley 1.47M sh · $1.93M · Q2 2026
- Renaissance Technologies 1.34M sh · $1.76M · Q2 2026
- Marshall Wace 1.28M sh · $1.68M · Q2 2026
- UBS Group AG 687.05K sh · $900.04K · Q2 2026
- Charles Schwab Investment Management 577.43K sh · $756.44K · Q2 2026
- Goldman Sachs Group 433.27K sh · $567.58K · Q2 2026
- Bank of America Corp 424.37K sh · $555.93K · Q2 2026